Abstract
When activated, TRPV1 promotes neurogenic inflammation via neuropeptide signaling. However, drugs designed to directly block TRPV1 may impair its nociceptive roles, essential for tissue preservation. In this work, pain and swelling caused by neurogenic inflammation were mitigated after blocking PLCγ’s activity, modulating TRPV1’s activity without affecting normal chemosensitivity. This suggests that blocking PLCγ could be a new approach for the development of painkillers maintaining the physiological detection of harmful stimuli.
Funding Information
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (#2019/06982-6)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (#2022/00594-7)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (#2023/10572-3)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (PQ-2 #307739/2018-0)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (#88887.825233/2023-00)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (#2023/09168-3)

This publication has 64 references indexed in Scilit: